• Citer

Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial.

par Demeestere, Isabelle ;Brice, Pauline;Peccatori, Fedro Alessandro;Kentos, Alain ;Gaillard, I.;Zachée, Pierre;Casasnovas, O.;Van Den Neste, Eric;Dechene, Julie ;De Maertelaer, Viviane ;Bron, Dominique ;Englert, Yvon
Référence Journal of clinical oncology, 31, 7, page (903-909)
Publication Publié, 2013-03

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial.
Auteur:	Demeestere, Isabelle; Brice, Pauline; Peccatori, Fedro Alessandro; Kentos, Alain; Gaillard, I.; Zachée, Pierre; Casasnovas, O.; Van Den Neste, Eric; Dechene, Julie; De Maertelaer, Viviane; Bron, Dominique; Englert, Yvon
Informations sur la publication:	Journal of clinical oncology, 31, 7, page (903-909)
Statut de publication:	Publié, 2013-03
Sujet CREF:	Gynécologie
	Cancérologie
MeSH keywords:	Adult
	Antineoplastic Combined Chemotherapy Protocols -- administration & dosage -- adverse effects
	Biological Markers -- blood
	Drug Therapy, Combination
	Estradiol -- blood
	Female
	Follicle Stimulating Hormone -- blood
	Follow-Up Studies
	Gonadotropin-Releasing Hormone -- agonists
	Hodgkin Disease -- drug therapy
	Humans
	Luteolytic Agents -- therapeutic use
	Lymphoma -- drug therapy
	Lymphoma, Non-Hodgkin -- drug therapy
	Middle Aged
	Norethindrone -- therapeutic use
	Premenopause
	Primary Ovarian Insufficiency -- blood -- chemically induced -- prevention & control
	Prospective Studies
	Time Factors
	Treatment Failure
	Triptorelin Pamoate -- therapeutic use
Note générale:	Journal Article
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0732-183X
	info:doi/10.1200/JCO.2012.42.8185
	info:pii/JCO.2012.42.8185
	info:scp/84875696905
	info:pmid/23129737